Global Renal Denervation (RDN) System Market Growth 2025-2031

The global Renal Denervation (RDN) System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Renal Denervation (RDN) is a percutaneous interventional treatment method. It mainly uses energy such as radio frequency and ultrasound to eliminate the afferent and efferent nerves in the renal artery, blocking the signal conduction between the brain and sympathetic nerves to a certain extent, thereby reducing the risk of high blood pressure. The sympathetic nerve excitability of patients with high blood pressure can achieve long-term and stable blood pressure lowering effects with one minimally invasive surgery.

Currently, the typical models of Renal Denervation (RDN) System include Recor Medical’s Paradise and Medtronic’s Simplicity Spyral, etc.

United States market for Renal Denervation (RDN) System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Renal Denervation (RDN) System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Renal Denervation (RDN) System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Renal Denervation (RDN) System players cover Medtronic, Recor Medical, Boston Scientific, Cardiosonic, Shanghai Bioheart, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Renal Denervation (RDN) System Industry Forecast” looks at past sales and reviews total world Renal Denervation (RDN) System sales in 2024, providing a comprehensive analysis by region and market sector of projected Renal Denervation (RDN) System sales for 2025 through 2031. With Renal Denervation (RDN) System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Denervation (RDN) System industry.

This Insight Report provides a comprehensive analysis of the global Renal Denervation (RDN) System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Renal Denervation (RDN) System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Denervation (RDN) System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Denervation (RDN) System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Denervation (RDN) System.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Denervation (RDN) System market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Radiofrequency Ablation
Ultrasound Ablation
Others

Segmentation by Application:
High Blood Pressure Treatment
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Recor Medical
Boston Scientific
Cardiosonic
Shanghai Bioheart
Shanghai Golden Leaf
Suzhou SyMap
MicroPort
Cryofocus Medtech
Shanghai Hantong

Key Questions Addressed in this Report

What is the 10-year outlook for the global Renal Denervation (RDN) System market?

What factors are driving Renal Denervation (RDN) System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Renal Denervation (RDN) System market opportunities vary by end market size?

How does Renal Denervation (RDN) System break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Renal Denervation (RDN) System by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Renal Denervation (RDN) System by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings